Dihydroergotamine Mesylate
Dihydroergotamine Mesylate Brand names, Dihydroergotamine Mesylate Analogs
- Agit
- Angionorm
- D.H.E.
- D.H.E. 45
- DET MS
- DHE-45
- Dergotamine
- Diergo
- Dihidroergotamina [INN-Spanish]
- Dihydergot
- Dihydroergotamine mesylate
- Dihydroergotamine methanesulfonate
- Dihydroergotamine monomethanesulfonate
- Dihydroergotaminum [INN-Latin]
- Dirgotarl
- Endophleban
- Ergomimet
- Ergont
- Ergotamine, 9,10-dihydro-
- Ergotonin
- Ikaran
- Migranal
- Morena
- Orstanorm
- Tonopres
- Verladyn
Dihydroergotamine Mesylate Brand Names Mixture
- No information avaliable
Dihydroergotamine Mesylate Chemical_Formula
C33H37N5O5
Dihydroergotamine Mesylate RX_link
http://www.rxlist.com/cgi/generic2/dihyergmes.htm
Dihydroergotamine Mesylate fda sheet
Dihydroergotamine Mesylate msds (material safety sheet)
Dihydroergotamine Mesylate Synthesis Reference
No information avaliable
Dihydroergotamine Mesylate Molecular Weight
583.678 g/mol
Dihydroergotamine Mesylate Melting Point
No information avaliable
Dihydroergotamine Mesylate H2O Solubility
No information avaliable
Dihydroergotamine Mesylate State
Solid
Dihydroergotamine Mesylate LogP
No information avaliable
Dihydroergotamine Mesylate Dosage Forms
Liquid
Dihydroergotamine Mesylate Indication
For the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes.
Dihydroergotamine Mesylate Pharmacology
Dihydroergotamine is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. Dihydroergotamine binds with high affinity to 5-HT1Da and 5-HT1Db receptors. It also binds with high affinity to serotonin 5-HT1A, 5-HT2A, and 5-HT2C receptors, noradrenaline a2A, a2B and a receptors, and dopamine D2L and D3 receptors. The therapeutic activity of Dihydroergotamine in migraine is generally attributed to the agonist effect at 5-HT1D receptors.
Dihydroergotamine Mesylate Absorption
Interpatient variable and may be dependent on the administration technique
Dihydroergotamine Mesylate side effects and Toxicity
Side effects include abdominal pain, abnormal speech, coma, confusion, convulsions, hallucinations, increase and/or decrease in blood pressure, nausea, numbness, tingling, pain, and a bluish color of your fingersand toes, slowed breathing, vomiting
Dihydroergotamine Mesylate Patient Information
PATIENT INFORMATIOn
Follow the link below to get detailed information before taking D.H.E. 45� (dihydroergotamine mesylate) Injection.
http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm
Follow the link below to get detailed information before taking D.H.E. 45� (dihydroergotamine mesylate) Injection.
http://www.rxlist.com/cgi/generic2/dihyergmes_pi.htm
Dihydroergotamine Mesylate Organisms Affected
Humans and other mammals
